Siga Technologies INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Siga Technologies INC stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for fiscal 2023 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for fiscal 2020 was $0.00.
- Siga Technologies INC stock issued during period, value, stock options exercised for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Siga Technologies INC stock issued during period, value, stock options exercised for fiscal 2018 was $261.88K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.20K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $261.88K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | $261.88K derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $9.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $261.88K 10-K · filed 2021-03-04 |
| 2018-09-30 | $252.68K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |